COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,238,000 | +47.7% | 61,106 | +61.1% | 0.06% | +44.4% |
Q2 2019 | $838,000 | +3.8% | 37,927 | -35.9% | 0.04% | +9.8% |
Q1 2019 | $807,000 | +169.9% | 59,165 | +79.0% | 0.04% | +141.2% |
Q4 2018 | $299,000 | -38.2% | 33,060 | +12.7% | 0.02% | -19.0% |
Q3 2018 | $484,000 | +17.2% | 29,335 | -0.6% | 0.02% | +110.0% |
Q2 2018 | $413,000 | +69.3% | 29,515 | +73.7% | 0.01% | +66.7% |
Q2 2017 | $244,000 | – | 16,995 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |